ProfileGDS4718 / 1560537_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 7% 14% 21% 19% 16% 16% 13% 20% 15% 20% 17% 16% 21% 17% 13% 17% 20% 17% 18% 11% 21% 19% 14% 19% 16% 18% 16% 13% 13% 26% 18% 17% 21% 20% 15% 18% 19% 17% 18% 22% 20% 22% 16% 13% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.675317
GSM549102patient 115, normal, homogenized [OPG study]3.9427514
GSM549104patient 119, normal, homogenized [OPG study]4.1391921
GSM549108patient 138, normal, homogenized [OPG study]4.1388319
GSM549119patient 077, normal, homogenized [OPG study]4.0194316
GSM549133patient 032, cancer, homogenized [OPG study]3.9716116
GSM549139patient 042, cancer, homogenized [OPG study]3.8623813
GSM549099patient 107, normal, homogenized [OPG study]4.1648620
GSM549109patient 139, normal, homogenized [OPG study]3.9932215
GSM549110patient 046, normal, homogenized [OPG study]4.1557220
GSM549114patient 063, normal, homogenized [OPG study]4.0110517
GSM549122patient 082, normal, homogenized [OPG study]3.9940816
GSM549134patient 033, cancer, homogenized [OPG study]4.1926921
GSM549136patient 036, cancer, homogenized [OPG study]3.9679417
GSM549140patient 044, cancer, homogenized [OPG study]3.8534113
GSM549111patient 047, normal, homogenized [OPG study]4.0131717
GSM549113patient 057, normal, homogenized [OPG study]4.0963720
GSM549132patient 031, cancer, homogenized [OPG study]4.0184817
GSM549137patient 038, cancer, homogenized [OPG study]4.0536818
GSM549142patient 047, cancer, homogenized [OPG study]3.894111
GSM549100patient 110, normal, homogenized [OPG study]4.2029521
GSM549107patient 135, normal, homogenized [OPG study]4.0595319
GSM549115patient 068, normal, homogenized [OPG study]3.8988414
GSM549116patient 072, normal, homogenized [OPG study]4.0938119
GSM549120patient 078, normal, homogenized [OPG study]4.0037716
GSM549131patient 030, cancer, homogenized [OPG study]4.0268218
GSM549118patient 074, normal, homogenized [OPG study]3.997716
GSM549129patient 027, cancer, homogenized [OPG study]3.9088513
GSM549123patient 088, normal, homogenized [OPG study]3.9015813
GSM549124patient 006, cancer, homogenized [OPG study]4.4073626
GSM549126patient 015, cancer, homogenized [OPG study]4.0673718
GSM549128patient 025, cancer, homogenized [OPG study]3.99517
GSM549103patient 117, normal, homogenized [OPG study]4.2160121
GSM549117patient 073, normal, homogenized [OPG study]4.1234920
GSM549138patient 041, cancer, homogenized [OPG study]3.9535215
GSM549141patient 045, cancer, homogenized [OPG study]4.0010118
GSM549130patient 028, cancer, homogenized [OPG study]4.1362519
GSM549101patient 111, normal, homogenized [OPG study]4.027117
GSM549105patient 128, normal, homogenized [OPG study]4.0805318
GSM549106patient 134, normal, homogenized [OPG study]4.1553422
GSM549112patient 048, normal, homogenized [OPG study]4.1492120
GSM549125patient 011, cancer, homogenized [OPG study]4.2414922
GSM549127patient 024, cancer, homogenized [OPG study]3.9606616
GSM549135patient 035, cancer, homogenized [OPG study]3.8276113